Deprenyl at 24% greater longevity may also be beneficial, as could genetically modifying rodents to make more GDF-11 protein (I think I read female mice that overexpress GDF-11 live 47% longer). The combination of a longevity drug with a wider new area
of testing out antiatherosclerosis drugs and gene therapies could be a beneficial new research protocol.

A kind of sideways approach to a new antidepressant and possibly anti-atherosclerotic is, noticing that stress causes macrophage activity that causes plaque build up and rupture, do something with the immune system that reduces, but to within normal
range, macrophage activity; I may have read that when antigens are placed in some kind of phospholipid packaging or moietyization, that the person actually becomes less allergic to something they were previously sensistized to. If they made a pie chart
of all the the things a normal person, as a well as an atherosclerotic person, as well as a depressed person are immunoreactive to then compare these three, to make a subset list, that provides a briefer list of things to do a possible immunopassivation
therapy about, to decrease atherosclerotic reactivity, and also reduce the atherosclerotic stress from mental nonoptimality (stressy personality; depression).

Using a genetic alorithm to develop immunopassivation molecules and moieties; Note 100-1000 endogenous immunoreactive chemicals, then do a a kind of combinatorial phospholipid where the potential passivating moiety is a single variant on 1000 versions,
such as length, liposomal anti-innumunogen passivation.

The internet has numerous immunopassivation and antigen desensitization drugs and protocols online.

immunopassivation (phospholipid moiety) of toxoplasmosis gondii antibodies could have mental health benefits (reference: the connection between cats and mental illness), reducing nonoptimal mental effects of toxoplasmosis gondii.

Shift (night) work is associated with less optimal health and possibly even nonoptimal longevity effects. It is possible using monozygotic twin human volunteers that that one could simulate shift (night) work, and the the other could continue day based
activities. Immunoreactivity profiles of the two styles could be made, and then if there are any differences in the specific things new antibodies are made to either day/night then they could test an immunization to either mop up the deleterious shift
work chemicals at the circulatory system, or immunopassivate (phospholipid moiety) existing antigens.
engineering, chemistry, computer ic, computer fab, longevity, longevity technology, treon, treon verdery, physics, lasers, laser, emiconductor, dimension, math, IT, IL, pattern resonance, time travel, chronotechnology, circile, eric the circle, cartoon,
healthspan, youthspan, cpi, manufacturing, fiscal, money, software, petroleum, archive at deviantart com user treonsebastia

All technologies, ideas, and inventions of Treon Sebastian Verdery are public domain at JUly 8,2023AD and previously, as well as after that date

--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)